You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
外交部:中国向「新冠肺炎疫苗实施计划」提供1,000万剂疫苗
阿思达克 02-03 16:04
外交部发言人汪文斌表示,中国已正式加入「新冠肺炎疫苗实施计划」(COVAX),决定向实施计划提供1,000万剂疫苗,主要用於发展中国家急需。

世卫组织已开始审核中国疫苗的紧急使用授权,中国企业将继续积极配合,希望世卫组织尽早完成这项工作。

汪文斌强调,中方希望国际社会有能力的国家都积极行动起来,以实际行动支持实施计划,支持世卫组织工作,帮助发展中国家及时获得疫苗,为国际社会早日战胜疫情作出应有的贡献。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account